Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

(2021) Alexis Moscoso et al.   JAMA Neurology

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

(2021) Niklas Mattsson‐Carlgren et al.   EMBO Molecular Medicine

Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau

(2021) Shorena Janelidze et al.   Alzheimers & Dementia

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

(2021) Joana B Pereira et al.   BRAIN

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

(2021) D. O. T. Alawode et al.   JOURNAL OF INTERNAL MEDICINE

Comparing the Clinical Utility and Diagnostic Performance of Cerebrospinal Fluid P-Tau181, P-Tau217 and P-Tau231 Assays

(2021) Antoine Leuzy et al.   NEUROLOGY

Phenotyping Alzheimer's disease with blood tests

(2021) Kaj Blennow   SCIENCE

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

(2021) Shorena Janelidze et al.   JAMA Neurology

Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities

(2021) Jeremy A. Syrjanen et al.   Alzheimers & Dementia

β-amyloid burden predicts prospective decline in body mass index in clinically normal adults

(2020) Jennifer S. Rabin et al.   NEUROBIOLOGY OF AGING

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels

(2020) Ali Manouchehrinia et al.   Annals of Clinical and Translational Neurology

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

(2020) Sebastian Palmqvist et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease

(2020) Eske Christiane Gertje et al.   NEUROLOGY

Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease

(2020) Andréa L Benedet et al.   BRAIN

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

(2019) Niklas Mattsson et al.   JAMA Neurology

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

(2019) Suzanne E. Schindler et al.   NEUROLOGY

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

(2019) Sebastian Palmqvist et al.   JAMA Neurology

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

(2018) Oskar Hansson et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

(2018) Akinori Nakamura et al.   NATURE

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

(2016) Magnus Gisslén et al.   EBioMedicine

Plasma β-amyloid in Alzheimer’s disease and vascular disease

(2016) Shorena Janelidze et al.   Scientific Reports

Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis

(2013) J.-M. Bugnicourt et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

(2012) Lesley A. Inker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

(2011) Michael Ewers et al.   NEUROBIOLOGY OF AGING